Skip to main content
S 2057 115th Congress Senate Government Operations and Politics

Pharmaceutical Regulation Conflict of Interest Act

Introduced: November 1, 2017 Introduced by: Baldwin, Tammy Democratic · Wisconsin See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 1, 2017
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Nov 1, 2017
Introduced in Senate
 Plain-English summary Congressional Research Service

Pharmaceutical Regulation Conflict of Interest Act

This bill amends the Ethics in Government Act of 1978 to prohibit a pharmaceutical regulator from using his or her position as regulator to influence any matter that provides a direct or substantial pecuniary benefit to a former employer or client. The position of pharmaceutical regulator refers to any officer or employee occupying a supervisory position within the Drug Enforcement Administration or the Food and Drug Administration.

The bill also prohibits such a pharmaceutical regulator from participating in matters involving an individual or entity with whom the pharmaceutical regulator is negotiating future employment.

The bill expands restrictions on lobbying by such pharmaceutical regulators following separation from employment with a pharmaceutical regulatory agency.

What's happening now November 1, 2017

Read twice and referred to the Committee on Homeland Security and Governmental Affairs.

 Committees of jurisdiction 1
 Cosponsors 4
All 4 Democratic 4